N. Keen
Oncology · 2004–2017
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Oncology — 26 citations into it; #1,686 of 1,698 by trust here, #1,139 by citations
- Cell Biology — 13 citations into it; #2,055 of 2,073 by trust here, #1,528 by citations
Whom N. Keen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts N. Keen overall
Papers from N. Keen's perspective
Ordered by how strongly the researchers N. Keen trusts endorse each paper. Same corpus, a different order for every researcher.
- Cell division: Mitotic kinases as regulators of cell division and its checkpoints (Nature reviews. Molecular cell biology)
- Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. (Cell)
- AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. (Cancer Cell)
- Drosophila Aurora B Kinase Is Required for Histone H3 Phosphorylation and Condensin Recruitment during Chromosome Condensation and to Organize the Central Spindle during Cytokinesis (Journal of Cell Biology)
- The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint (Journal of Cell Biology)
- Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53 (Nature Genetics)
- Visualizing Data using t-SNE
- The cellular geography of Aurora kinases (Nature reviews. Molecular cell biology)
- The spindle checkpoint: structural insights into dynamic signalling (Nature reviews. Molecular cell biology)
- International network of cancer genome projects (Nature)
Their papers
- Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening. (2017) — 599 citations
- Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases (2016) — 795 citations
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response (2015) — 1,236 citations
- Aurora-kinase inhibitors as anticancer agents (2004) — 668 citations